March 13, 2018 | Denise Heady
Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.
Surprising Diagnosis Leads Skin Cancer Patient to City of Hope
May 29, 2018 | Robert Young
Barbara Dorfman ran a large nursery school for 25 years, helped raise five children and has enjoyed an exceptionally active lifestyle with her husband, but nothing could prepare her for the diagnosis she received four years ago.
Patient with Rare Skin Cancer Grateful for City of Hope Dermatology Team
May 22, 2018 | Robert Young
When what he thought was just a rash on his forehead spread to his face and neck, Joshua Singer sought medical help. After a number of treatments failed to figure out the problem, he turned to City of Hope, and renowned dermatologist Christiane Querfeld. M.D., Ph.D.
The Many Types of Skin Cancer: What You Should Know
May 21, 2018 | Kevin Chesley
Skin cancer is a largely survivable and curable form of cancer. Even its most rare and aggressive form, melanoma, has a high cure rate thanks to leading-edge treatments. But it’s still important to be careful, according to City of Hope Christiane Querfeld, M.D., Ph.D.
City of Hope to offer CAR T cell therapy for patients with the most common type of NHL
May 4, 2018 | Letisia Marquez
City of Hope recently announced that it is one of the first treatment centers certified in the United States to administer tisagenlecleucel CAR T cell therapy to adult patients with relapsed or refractory large B cell lymphoma.
Cheryl’s Story: CAR T Patient and Pioneer
April 30, 2018 | Letisia Marquez
Cheryl Wiers knew her cancer diagnosis happened for a reason, and for her, that reason could be her participation in a clinical trial using what is arguably the most promising cancer treatment — CAR T cell therapy.
City of Hope Researchers Find “Achilles' Heel” in B Cell Tumors
March 14, 2018 | Katie Neith
In a new paper published in the journal Cell, a team of researchers led by City of Hope’s Markus Müschen, M.D., Ph.D., and Gang Xiao, Ph.D., reports on the discovery of a new therapeutic target for these B cell malignancies.
‘Goldilocks’ Therapies Could Be a Breakthrough for Patients with Lymphoma
March 6, 2018 | City of Hope
Thanks to research being done by City of Hope's Markus Müschen, M.D., Ph.D., lymphoma patients may soon receive treatments that leverage quality control mechanisms that our own immune systems utilize to fight harmful antibodies.
5 Things to Know About Skin Cancer
February 5, 2018 | Kevin Chesley
Skin cancer is the most commonly diagnosed malignancy. Most forms are not life-threatening, except for the rarest form, melanoma. However, even this most aggressive form of skin cancer has a high cure rate, thanks to new leading-edge treatments.